Hasil Pencarian - Shekhar Patil

  • Menampilkan 1 - 8 hasil dari 8
Perbaiki Hasil
  1. 1
    Utility of EBUS-TBNA in PET-positive mediastinal lymph nodes in subjects with extra-thoracic malignancy.

    Utility of EBUS-TBNA in PET-positive mediastinal lymph nodes in subjects with extra-thoracic malignancy. oleh Ravindra M Mehta, Pavankumar Biraris, Shekhar Patil, Abhinav Singla, Kumar Kallur, Stefano Gasparini

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Transarterial Radioembolization (TARE) with 131Iodine-Lipiodol for Unresectable Primary Hepatocellular Carcinoma: Experience from a Tertiary Care Center in India

    Transarterial Radioembolization (TARE) with 131Iodine-Lipiodol for Unresectable Primary Hepatocellular Carcinoma: Experience from a Tertiary Care Center in India oleh Aakash Patel, Indusekhara Subbanna, Vidya Bhargavi, Shivakumar Swamy, Kumarswamy G. Kallur, Shekhar Patil

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Expanding the spectrum of HEXA mutations in Indian patients with Tay–Sachs disease

    Expanding the spectrum of HEXA mutations in Indian patients with Tay–Sachs disease oleh Jayesh Sheth, Mehul Mistri, Chaitanya Datar, Umesh Kalane, Shekhar Patil, Mahesh Kamate, Harshuti Shah, Sheela Nampoothiri, Sarita Gupta, Frenny Sheth

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study

    Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study oleh Sudeep Gupta, Senthil Rajappa, Suresh Advani, Amit Agarwal, Shyam Aggarwal, Chanchal Goswami, Satya Dattatreya Palanki, Devavrat Arya, Shekhar Patil, Rohit Kodagali

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Phenotyping Post-COVID Pain as a Nociceptive, Neuropathic, or Nociplastic Pain Condition

    Phenotyping Post-COVID Pain as a Nociceptive, Neuropathic, or Nociplastic Pain Condition oleh César Fernández-de-las-Peñas, Jo Nijs, Randy Neblett, Andrea Polli, Maarten Moens, Lisa Goudman, Madhura Shekhar Patil, Roger D. Knaggs, Gisele Pickering, Lars Arendt-Nielsen

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    HR+HER2− breast cancers with growth factor receptor–mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells

    HR+HER2− breast cancers with growth factor receptor–mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells oleh Krisha Desai, Radhika Aiyappa, Jyothi S Prabhu, Madhumathy G Nair, Patrick Varun Lawrence, Aruna Korlimarla, Anupama CE, Annie Alexander, Rohini S Kaluve, Suraj Manjunath, Marjorrie Correa, BS Srinath, Shekhar Patil, Anjali Kalamdani, MSN Prasad, TS Sridhar

    Diterbitkan 2017-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Survival of Trial-Like and Non–Trial-Like Patients With Immunotherapy in Advanced Hepatocellular Carcinoma in Real World: A Collaborative Multicenter Indian Study (IMHEP)

    Survival of Trial-Like and Non–Trial-Like Patients With Immunotherapy in Advanced Hepatocellular Carcinoma in Real World: A Collaborative Multicenter Indian Study (IMHEP) oleh Anant Ramaswamy, Anand Kulkarni, George John, Amit Rauthan, Shekhar Patil, Ajay Duseja, Vineet Talwar, Senthil J. Rajappa, Nikhil Ghadyalpatil, Manav Wadhawan, Akash Shukla, Vamshi M. Krishna, Sujay Srinivas, Sunil Taneja, K. Mary Sravani, Sahaj Rathi, Prabhat Bhargava, Vikas Ostwal

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India

    Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India oleh Purvish M. Parikh, Gouri Shankar Bhattacharyya, Ghanshyam Biswas, Arvind Krishnamurty, Dinesh Doval, Anil Heroor, Sanjay Sharma, Ramakant Deshpande, Harit Chaturvedi, S. P. Somashekhar, Govind Babu, G. Krishna Reddy, Diptendra Sarkar, Chirag Desai, Hemant Malhotra, Nitesh Rohagi, Ajay Bapna, S. S. Alurkar, Prasad Krishna, S. V.S. Deo, Anurag Shrivastava, Prakash Chitalkar, Saroj Kumar Majumdar, Devanhalli Vijay, Aniket Thoke, K. S. Udupa, Jyoti Bajpai, G. K. Rath, Palanki Satya Dattatreya, Shailesh Bondarde, Shekhar Patil

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: